-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-2-noninvasive-nonpharma.xlsx
January 01, 2021 - 3 to 4 spondylolisthesis; fibromyalgia , or systemic/inflammatory disorder, current lower extremity musculoskeletal … vs. 2.93 (0.93), p=0.15 NR NR NR Supported by a grant from the National Institute of Arthritis and Musculoskeletal … 126) vs. 0% (0/124) Supported by grants 1R01AR059105-01 from the National Institute of Arthritis and Musculoskeletal … calculable (NC)
Not reported (NR)
Numerical Pain Scale (NPS)
Numerical Rating Scale (NRS)
Örebro Musculoskeletal
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-executive-summary-2023-update.pdf
January 01, 2023 - 57% 57%
% Non-White
(Study Count)
54% (1); NR (5) NR NR NR NR
Primary Pain
Type(s)
Mixed
musculoskeletal
-
effectivehealthcare.ahrq.gov/health-topics/vitiligo
-
effectivehealthcare.ahrq.gov/health-topics/marfan-syndrome
-
effectivehealthcare.ahrq.gov/health-topics/scleroderma/
-
effectivehealthcare.ahrq.gov/health-topics/scoliosis
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/topic-brief3-SUD.pdf
April 01, 2021 - December 4, 2020
1 Chronic Pain/
2 exp arthralgia/ or exp back pain/ or exp headache/ or exp musculoskeletal … product-details.901.html
https://www.clinicaltrials.gov/
A-2
7 (((back or spine or spinal or leg or musculoskeletal
-
effectivehealthcare.ahrq.gov/health-topics/acne
-
effectivehealthcare.ahrq.gov/health-topics/hip-replacement/
-
effectivehealthcare.ahrq.gov/health-topics/osteogenesis-imperfecta
-
effectivehealthcare.ahrq.gov/health-topics/rheumatoid-arthritis/
-
effectivehealthcare.ahrq.gov/health-topics/rotator-cuff-injuries/
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/fibromyalgia_disposition-comments.pdf
January 26, 2015 - We edited the statement in ES-1
and the Report Background to: Fibromyalgia is
a chronic, diffuse musculoskeletal … edited the statement in the ES and Report
and added references: Fibromyalgia is a
chronic, diffuse musculoskeletal … Supported by NIH grant N01-AR-2-2264 from the National
Institute of Arthritis and Musculoskeletal and
-
effectivehealthcare.ahrq.gov/products/osteoporosis-fracture-prevention/research-protocol
April 12, 2018 - denosumab: Osteonecrosis of the jaw, atypical femoral fracture, atrial fibrillation, heart attacks, musculoskeletal … not applicable
NIA
National Institute on Aging
NIAMS
National Institute of Arthritis and Musculoskeletal
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain_executive.pdf
October 01, 2011 - Impact of
musculoskeletal disorders in Canada. … Musculoskeletal disorders. Non-steroidal anti-
inflammatory drugs.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-evidence-summary-2022-update_0.pdf
January 01, 2022 - 55% 57% 59% 57%
% Non-White (Study
Count)
54% (1); NR (4) NR NR NR
Primary Pain Type(s) Mixed
musculoskeletal
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/research-protocol-osteoporosis_2.pdf
October 05, 2018 - denosumab: Osteonecrosis of
the jaw, atypical femoral fracture, atrial fibrillation, heart
attacks, musculoskeletal … NA not applicable
NIA National Institute on Aging
NIAMS National Institute of Arthritis and Musculoskeletal
-
effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-ape_0.xlsx
August 08, 2017 - Heart Foundation)
Derry, 2016
(Good) To evaluate efficacy and safety of topical NSAIDs for chronic musculoskeletal … topical diclofenac vs. carrier, 2 topical diclofenac vs. oral diclofenac Adults (≥16 years) with chronic musculoskeletal
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-diagnosis_executive.pdf
June 01, 2012 - These
may be patients with atypical chest pain (e.g., reflux or
musculoskeletal disease) who are concerned … would not apply to patients with
low pretest probability of disease (e.g., gastroesophageal
reflux, musculoskeletal
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f1-f4-tables-surveillance-report-2.xlsx
January 22, 2022 - 2 mg/day Placebo 2 mg/day NA NA NA NA 9 Short Industry Moderate
34510141 Vela, 2021 RCT No Denmark Musculoskeletal … NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA NR NR NA NA NR NR NR NR NR NR
Vela, 2021 None Moderate Musculoskeletal … NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA NR NR NA NA NR NR NR NR NR NR
Vela, 2021 None Moderate Musculoskeletal … Vela, 2021 None Moderate Musculoskeletal Hand osteoarthritis and psoriatic arthritis Synthetic CBD 10 … NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR Musculoskeletal